Answers are grounded in this paper and cite their sources.
Significance G protein-coupled receptors (GPCRs) are involved in many physiological processes and important drug targets. However, most therapeutic agents targeting GPCRs, such as the coreceptors of HIV-1 CCR5 and CXCR4, also interfere with their signaling function. Here, we used primate lentiviruses as tools to discover novel endogenous ligands of GPR15, a coreceptor for HIV-2 and SIV proposed to play a role in mucosal immunity. We found that C-terminal fragments of cystatin C generated by immune-activated proteases inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L chemokine signaling. Thus, we identified an endogenous bioactive peptide that specifically prevents the detrimental activity of a GPCR (i.e. virus infection) without compromising its physiological signaling function.
No takes yet. Share an insight, caveat, or question.
Hayn et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: